s acetyl glutathione bioavailability S-Acetyl L-Glutathione Supplement Discover the Original S-Acetyl Glutathione

Neither Limitless Biotech nor Peptide Sciences offers that level of transparency

For any new cancer therapy to be considered reliable, it must demonstrate: Safety through Phase 1 clinical trials Early effectiveness through Phase 2 trials Clear benefit compared to standard treatment in Phase 3 trials Peer-reviewed publication in medical journals Regulatory approval by recognised authorities Current Evidence Status of Enteromix Based on publicly available information: No Phase 3 human clinical trial results have been published No validated tumour response rates are available No survival benefit data has been released No approvals exist from international or Indian regulators While mRNA cancer vaccines are an active area of global research, Enteromix does not currently meet the standards of evidence-based cancer treatment

Archived from the original (PDF) on 20 October 2013

The protein is 42 kDa unglycosylated and 63 kDa when glycosylated